Myriad Genetics, Inc. (LON:0K3W)
London · Delayed Price · Currency is GBP · Price in USD 5.31
+0.07 (1.34%)
Feb 5, 2026, 3:10 PM GMT
Myriad Genetics Market Cap
Myriad Genetics has a market cap or net worth of 361.79 million as of February 5, 2026. Its market cap has decreased by -61.05% in one year.
Market Cap
361.79M
Enterprise Value
410.78M
Revenue
613.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.31
Market Cap Chart
Since October 6, 1995, Myriad Genetics's market cap has increased from 110.60M to 361.79M, an increase of 227.11%. That is a compound annual growth rate of 3.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 361.79M | -15.06% |
| Dec 31, 2025 | 425.94M | -57.28% |
| Dec 31, 2024 | 996.94M | -25.18% |
| Dec 29, 2023 | 1.33B | 36.53% |
| Dec 30, 2022 | 975.86M | -40.05% |
| Dec 31, 2021 | 1.63B | 49.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 213.97B |
| GSK plc | 83.47B |
| Haleon | 35.18B |
| Smith & Nephew | 10.86B |
| Craneware | 569.91M |
| Advanced Medical Solutions Group | 472.57M |
| PureTech Health | 318.06M |
| NIOX Group | 275.00M |